ENTITY
Eisai Co Ltd

Eisai Co Ltd (4523 JP)

103
Analysis
Health CareJapan
Eisai Co., Ltd. produces prescription drugs and medical equipment and sells mainly to sales agents and subsidiaries. Through its subsidiary, Sanko Junyaku, the Company produces and sells diagnostic drugs. Eisai also markets its products through related companies in the US, Europe, and Asia. The Company also manufactures and sells foods, livestock feeds, chemical, and agrochemicals.
more
Refresh
21 Sep 2016 09:03

ANIMAL SPIRITS™ REPORT: Japan Equity Market Outlook - Escaping The Value Trap

Investment Conclusions We are currently "neutral" in our view on Japan in global developed market portfolios but "underweight" in our APAC...

Share
16 Sep 2016 07:57

Takeda Pharmaceutical - Is M&A the Way Out of Its Problems?

The FT has reported that Takeda Pharmaceutical may be back on the acquisition trail, with a US$15bil war-chest. This puts into the public domain a...

13 Sep 2016 19:39

Japan Stock Market Seasonality - Late Q4 Is Indeed Good

Pelham Smithers came out with a worthwhile comment on the Q4 seasonality of Japanese markets. I agree with their assessment of being bullish Japan...

Logo
246 Views
Share
05 Sep 2016 13:45

Short Sell Research Vs The Japan Stock Market Blob

Two recent press articles "Muddy Waters and Andrew Left: the short sellers having a ball" (...

29 Aug 2016 22:03

Japan Pharma Hits 52 Week Low

The Topix pharmaceutical index (TPPHRM) fell to 2,355 just after the lunch break in Tokyo on Friday 19th August, before recovering to 2,377, with...

x